by Mustapha Gidado, Executive Director, KNCV TB Plus.
Increased political will and financial investment — plus the application of lessons learned from the ongoing COVID-19 pandemic — are vital in tackling the scourge of tuberculosis (TB).
Read the full article in the insert of the New Scientist on Infectious Diseases through this link.
KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.
Our experts
KNCV governance framework and integrity
Our patroness
Partner with us
Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.
The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi
New drugs & treatment regimens
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centred Framework for National Strategic Planning and HSS
Blended learning platform & methodologies
ASCENT
ASTTIE
Development of a comprehensive Digital Training Package
E-detect
GeneXpert MTB/RIF Test
IMPAACT4TB
PAVIA
People-Centered Framework for TB Programming
PODTEC
TB Alliance BPAL Project
The Global Fund to Fight AIDS, Tuberculosis and Malaria
TREATS
Challenge TB
Improved TB/HIV Prevention & Care – Building Models for the Future Project
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania
De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.